» Articles » PMID: 25319102

Reduction-responsive Crosslinked Micellar Nanoassemblies for Tumor-targeted Drug Delivery

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2014 Oct 17
PMID 25319102
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of the study was to devise and evaluate crosslinked nanoassemblies to achieve enhanced drug delivery to tumors.

Methods: A novel copolymer comprised of polyethylene glycol 5000 (PEG114), Vitamin E (VE) and thioctic acid (TA) with a molar ratio of PEG114:VE:TA at 1:4:4 was synthesized. The resulting PEG114-VE4-TA4 copolymer self-assembled into micelles, which formed polydisulfide crosslinks catalyzed by dithiothreitol. Employing paclitaxel as a model drug, the crosslinked PEG114-VE4-TA4 micelles were characterized for the physicochemical and biological properties. The pharmacokinetics and anticancer efficacy of paclitaxel-loaded crosslinked PEG114-VE4-TA4 micelles were assessed in a human ovarian cancer xenograft murine model.

Results: The crosslinked PEG114-VE4-TA4 micelles demonstrated markedly improved thermodynamic and kinetic stability. The disulfide crosslinks were responsive to the intracellular level of glutathione, which caused rapid disassembly of the micelles and accelerated drug release. Intravenous administration of paclitaxel-loaded crosslinked PEG114-VE4-TA4 micelles yielded approximately 3-fold and 5-fold higher plasma concentration than the non-crosslinked micelles and Taxol®, respectively, leading to increased drug accumulation in the tumor. Importantly, paclitaxel-loaded crosslinked micelles exerted superior tumor growth repression compared to the non-crosslinked counterparts and Taxol®.

Conclusions: These results suggest that the crosslinked PEG114-VE4-TA4 nanocarrier system is a promising platform for the delivery of hydrophobic anticancer agents.

Citing Articles

Conjugated Linoleic Acid-Carboxymethyl Chitosan Polymeric Micelles to Improve the Solubility and Oral Bioavailability of Paclitaxel.

Mubeen I, Abbas G, Shah S, Assiri A Pharmaceutics. 2024; 16(3).

PMID: 38543236 PMC: 10974779. DOI: 10.3390/pharmaceutics16030342.


Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle.

Su Y, Huang N, Chen D, Zhang L, Dong X, Sun Y Int J Nanomedicine. 2017; 12:4019-4035.

PMID: 28603416 PMC: 5457155. DOI: 10.2147/IJN.S132639.


Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer.

Fan W, Shi W, Zhang W, Jia Y, Zhou Z, Brusnahan S Biomaterials. 2016; 103:101-115.

PMID: 27372424 PMC: 5018995. DOI: 10.1016/j.biomaterials.2016.05.036.


Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors.

Zhang Y, Zhou J, Yang C, Wang W, Chu L, Huang F Int J Nanomedicine. 2016; 11:1119-30.

PMID: 27051287 PMC: 4807950. DOI: 10.2147/IJN.S101649.

References
1.
Zhang Z, Tan S, Feng S . Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012; 33(19):4889-906. DOI: 10.1016/j.biomaterials.2012.03.046. View

2.
Chen H, Kim S, He W, Wang H, Low P, Park K . Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir. 2008; 24(10):5213-7. DOI: 10.1021/la703570m. View

3.
Kim S, Kim D, Shim Y, Bang J, Oh H, Wan Kim S . In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001; 72(1-3):191-202. DOI: 10.1016/s0168-3659(01)00275-9. View

4.
Shao Y, Huang W, Shi C, Atkinson S, Luo J . Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment. Ther Deliv. 2013; 3(12):1409-27. PMC: 3575096. DOI: 10.4155/tde.12.106. View

5.
Cheng Z, Al Zaki A, Hui J, Muzykantov V, Tsourkas A . Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science. 2012; 338(6109):903-10. PMC: 3660151. DOI: 10.1126/science.1226338. View